LEIDEN JEFFREY M 1242825 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-09 | 2023-05-05 | 2023-05-05 to 2023-05-08 | 4 | Leiden Jeffrey M | EXECUTIVE CHAIRMAN | dsp | 2004.0 | 5.36 | 0.08 | 349.25 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 35387.0
|
257.55 (VRTX) |
| 2023-05-09 | 2023-05-05 | 4 | Leiden Jeffrey M | EXECUTIVE CHAIRMAN | holding | 440.0 | 0 | 0.02 | 0.0 | 401(K) | Common Stock | VERTEX PHARMACEUTICALS INC / MA | NA | 257.55 (VRTX) | ||
| 2023-10-18 | 2023-10-16 | 2023-10-16 | 4 | Leiden Jeffrey M | EXECUTIVE CHAIRMAN | dsp | 12962.0 | 36.63 | 0.5 | 374.0 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 22425.0 | 258.09 (VRTX) |
| 2023-10-18 | 2023-10-16 | 4 | Leiden Jeffrey M | EXECUTIVE CHAIRMAN | holding | 440.0 | 0 | 0.02 | 0.0 | 401(K) | Common Stock | VERTEX PHARMACEUTICALS INC / MA | NA | 258.09 (VRTX) | ||
| 2023-12-15 | 2023-12-13 | 4 | Leiden Jeffrey M | EXECUTIVE CHAIRMAN | holding | 440.0 | 0 | 0.02 | 0.0 | 401(K) | Common Stock | VERTEX PHARMACEUTICALS INC / MA | NA | 257.68 (VRTX) | ||
| 2023-12-15 | 2023-12-13 | 2023-12-13 | 4 | Leiden Jeffrey M | EXECUTIVE CHAIRMAN | dsp | 13354.0 | 59.55 | 0.52 | 399.42 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 9071.0
|
257.68 (VRTX) |
| 2024-01-10 | 2024-01-08 | 2024-01-08 | 4 | Leiden Jeffrey M | EXECUTIVE CHAIRMAN | dsp | 6648.0 | 73.29 | 0.26 | 419.07 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 2423.0 | 257.68 (VRTX) |
| 2024-01-10 | 2024-01-08 | 4 | Leiden Jeffrey M | EXECUTIVE CHAIRMAN | holding | 440.0 | 0 | 0.02 | 0.0 | 401(K) | Common Stock | VERTEX PHARMACEUTICALS INC / MA | NA | 257.68 (VRTX) | ||
| 2024-02-08 | 2024-02-06 | 2024-02-06 to 2024-02-07 | 4 | Leiden Jeffrey M | EXECUTIVE CHAIRMAN | acq | 38623.0 | 94.1 | 1.5 | 0.0 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code A | 41046.0
|
257.68 (VRTX) |
| 2024-02-08 | 2024-02-06 | 4 | Leiden Jeffrey M | EXECUTIVE CHAIRMAN | holding | 440.0 | 0 | 0.02 | 0.0 | 401(K) | Common Stock | VERTEX PHARMACEUTICALS INC / MA | NA | 257.68 (VRTX) | ||
| 2024-02-12 | 2024-02-08 | 2024-02-08 to 2024-02-09 | 4 | Leiden Jeffrey M | EXECUTIVE CHAIRMAN | dsp | 10746.0 | 26.18 | 0.42 | 422.49 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F | 30300.0
|
257.68 (VRTX) |
| 2024-02-12 | 2024-02-08 | 4 | Leiden Jeffrey M | EXECUTIVE CHAIRMAN | holding | 440.0 | 0 | 0.02 | 0.0 | 401(K) | Common Stock | VERTEX PHARMACEUTICALS INC / MA | NA | 257.68 (VRTX) | ||
| 2024-02-14 | 2024-02-12 | 4 | Leiden Jeffrey M | EXECUTIVE CHAIRMAN | holding | 440.0 | 0 | 0.02 | 0.0 | 401(K) | Common Stock | VERTEX PHARMACEUTICALS INC / MA | NA | 257.68 (VRTX) | ||
| 2024-02-14 | 2024-02-12 | 2024-02-12 to 2024-02-13 | 4 | Leiden Jeffrey M | EXECUTIVE CHAIRMAN | dsp | 3393.0 | 11.2 | 0.13 | 419.42 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 26907.0
|
257.68 (VRTX) |
| 2024-02-16 | 2024-02-14 | 2024-02-14 to 2024-02-15 | 4 | Leiden Jeffrey M | EXECUTIVE CHAIRMAN | dsp | 9011.0 | 33.49 | 0.35 | 419.1 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 17896.0
|
258.31 (VRTX) |
| 2024-02-16 | 2024-02-14 | 4 | Leiden Jeffrey M | EXECUTIVE CHAIRMAN | holding | 440.0 | 0 | 0.02 | 0.0 | 401(K) | Common Stock | VERTEX PHARMACEUTICALS INC / MA | NA | 258.31 (VRTX) | ||
| 2024-02-21 | 2024-02-20 | 4 | Leiden Jeffrey M | EXECUTIVE CHAIRMAN | holding | 440.0 | 0 | 0.02 | 0.0 | 401(K) | Common Stock | VERTEX PHARMACEUTICALS INC / MA | NA | 258.31 (VRTX) | ||
| 2024-02-21 | 2024-02-20 | 2024-02-20 | 4 | Leiden Jeffrey M | EXECUTIVE CHAIRMAN | dsp | 4118.0 | 23.01 | 0.16 | 420.58 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F | 13778.0 | 258.31 (VRTX) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)